Wheaton aquires CELLine technology

Wheaton has acquired the CELLine dual membrane, cell culture flask line for antibody and protein production from Wilson Wolf Manufacturing Corporation. Wheaton has also entered into a long-term strategic partnership with Wilson Wolf Manufacturing for further product development in high-density cell culture devices for the production of concentrated, cell-secreted products.

CELLine flasks are suitable for small-scale suspension and adherent cultures. They are ready to use and disposable, producing high cell density and high product concentration while reducing culture and processing time. The dual membrane bioreactor system is designed as a humane alternative to hybridoma culture in the peritoneal cavity of mice, also known as the ascites method.

“We are excited to bring this innovative, high-growth technology to Wheaton and to our customers around the world,” said Stephen R Drozdow, President of Wheaton. “These products, combined with the existing Wheaton portfolio, support the advancement of antibody and protein research, development and production.

“We are also proud to have an ongoing partner with Wilson Wolf, for collaboration and further advancement of cell culture products.”